Di Leo A, Toi M, Campone M, et al. MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer. ESMO 2017, abstract 236O_PR.
Nieuw stadiëringsysteem geen grote impact op classificering T1-melanomen
aug 2018 | Dermato-oncologie